Businesses in the healthcare and pharmacy sectors sometimes rely on sales-based financing, such as merchant cash advance (MCA) structures, when facing short-term cash constraints. These products may provide fast access to capital, but they also come with characteristics that can create ongoing pressure, such as daily or weekly remittances tied to sales volume, factor rates instead of interest rates, and repayment timelines that may compress depending on business performance.
For companies seeking a more structured form of financing, Commercial & Industrial (C&I) loans can offer an alternative pathway. While not suitable for every type of business or credit profile, a C&I loan may help qualified borrowers improve predictability, stabilize monthly expenses, and access funds through a more traditional underwriting process.
Why Some Businesses Explore C&I Loans as an Alternative
1. Payment Structure May Align Better With Monthly Operations
C&I loans generally involve scheduled payments, commonly monthly, rather than daily or weekly remittances tied to revenue. For businesses working with reimbursement cycles, common in healthcare and pharmacy, this can create a manageable alignment between cash inflow and outflow.
2. Longer Repayment Timelines Depending on Underwriting
C&I loans may offer multi-year repayment terms, depending on lender approval. This can allow a business to spread out its obligations in a way that may reduce short-term financial strain compared with faster, sales-driven repayment structures.
3. Potentially Lower Cost of Capital Based on Qualification
Because C&I loans generally use interest-based pricing, qualified borrowers may find that their cost of capital is more favorable than structures using factor rates. Actual cost will vary based on credit strength, documentation, collateral, financial performance, and lender evaluation.
4. Can Support Broader Operational Needs
C&I loans can be used for working capital, equipment purchases, inventory, expansion, or to improve balance-sheet flexibility. For companies aiming to move away from high-pressure repayment schedules, this broader use-case range can be helpful.
How PharmaFlex Funds Helps Businesses Explore These Options
PharmaFlex Funds is a loan-sourcing company, not a lender. The role is to help business owners understand available funding pathways, evaluate potential lenders, and compare structures that may fit healthcare-specific operating models.
PharmaFlex Funds can help businesses:
- Explore C&I loan opportunities
- Identify lenders that work with pharmacies, small healthcare providers, and medically aligned businesses
- Compare funding structures to understand differences between sales-based financing and traditional loans
- Understand documentation requirements
Note: We do not provide financial advice or review financial statements. Lenders make all underwriting decisions.
- Consider alternatives outside C&I lending, such as equipment financing, AR-based funding, inventory credit lines, or working-capital products appropriate for healthcare industries
- Options may include bank and non-bank products. Structures vary by provider.
PharmaFlex Funds does not guarantee approvals or outcomes. Instead, the goal is to help owners evaluate what may be possible based on their qualifications, credit strength, business performance, and lender appetite.
Standard Disclosure
PharmaFlex Funds is not a lender. All financing is subject to lender underwriting, approval, and qualification requirements. Information provided here is for educational purposes only and is not legal, financial, or tax advice. Borrowers should consult their own advisors before making funding decisions. Rates, fees, and terms vary by lender and borrower profile.